Harbour Investment Management’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.9K | Hold |
10,100
| – | – | 0.01% | 94 |
|
|
2025
Q1 | $25.9K | Hold |
10,100
| – | – | 0.01% | 96 |
|
|
2024
Q4 | $19K | Hold |
10,100
| – | – | 0.01% | 98 |
|
|
2024
Q3 | $10.3K | Hold |
10,100
| – | – | ﹤0.01% | 91 |
|
|
2024
Q2 | $11.8K | Hold |
10,100
| – | – | 0.01% | 87 |
|
|
2024
Q1 | $12.7K | Hold |
10,100
| – | – | 0.01% | 88 |
|
|
2023
Q4 | $18K | Hold |
10,100
| – | – | 0.01% | 75 |
|
|
2023
Q3 | $16.8K | Hold |
10,100
| – | – | 0.01% | 74 |
|
|
2023
Q2 | $20.2K | Buy |
+10,100
| New | +$20.2K | 0.01% | 74 |
|